Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
LEUKEMIA
Interventions
DRUG

CAMPATH-1H

Day-8 through Day-6 according to institutional SOPs

DRUG

Anti-CD45

Day-5 400 μg/kg

DRUG

Ara-C

day-7 through day-5 3000 mg/m2 q 12h

DRUG

Cyclophosphamide

Day-7 through Day-6 45 mg/kg

DRUG

Mesna

Days -7 and -6 45 mg/kg divided into 5 doses

RADIATION

Total Body Irradiation

150 cGy x 2 (5/6 matched related) 180 cGy x 2 (5/6 matched unrelated)

Trial Locations (2)

77030

Texas Children's Hospital, Houston

The Methodist Hospital, Houston

All Listed Sponsors
collaborator

The Methodist Hospital Research Institute

OTHER

collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine

OTHER

lead

Baylor College of Medicine

OTHER

NCT00057005 - Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter